Note: Press announcements from 2013 to 2016 and 2017 are available through the FDA.gov Archive. Some links in press announcements may no longer be active. For more information, contact FDA’s Office of Media Affairs at 301-796-4540.

October 2021

• October 13, 2021 - To Improve Nutrition and Reduce the Burden of Disease, FDA Issues Food Industry Guidance for Voluntarily Reducing Sodium in Processed and Packaged Foods
• October 12, 2021 - Coronavirus (COVID-19) Update: October 12, 2021
• October 12, 2021 - FDA Permits Marketing of E-Cigarette Products, Marking First Authorization of Its Kind by the Agency
• October 8, 2021 - FDA Approves Innovative Treatment for Pediatric Patients with Congenital Athymia
• October 8, 2021 - Coronavirus (COVID-19) Update: October 8, 2021
• October 8, 2021 - FDA In Brief: FDA Warns Public and Health Care Professionals Not to Use Needle-free Devices for Injection of Dermal Fillers
• October 7, 2021 - FDA Issues Final Order and Guidance on Surgical Staplers and Staples for Internal Use
• October 7, 2021 - FDA Announces Signing of Domestic Mutual Reliance Agreements with California, Florida, Utah and Wisconsin
• October 7, 2021 - FDA In Brief: FDA Warns Firms for Continuing to Market E-cigarette Products After Agency Denied Authorizations
• October 6, 2021 - FDA Revises Hospital and Health System Compounding Guidance to Help Preserve Patient Access to Compounded Drugs